COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,357 Articles (22,803 medRxiv, 8,554 bioRxiv)

Most recent first Previous |  Page 2845: Articles 28441-28450  | Next

Pooling RT-PCR test of SARS-CoV-2 for large cohort of 'healthy' and infection-suspected patients: A prospective and consecutive study on 1,000 individuals
Hirotsu, Y., Maejima, M., Shibusawa, M., Nagakubo, Y., Hosaka, K., Amemiya, K., Sueki, H., Hayakawa, M., Mochizuki, H., Omata, M.
10.1101/2020.05.04.20088146 — Posted: 2020-05-06
A new role for Biofoundries in rapid prototyping, development, and validation of automated clinical diagnostic tests for SARS-CoV-2
Crone, M. A., Priestman, M., Ciechonska, M., Jensen, K., Sharp, D., Randell, P., Storch, M., Freemont, P.
10.1101/2020.05.02.20088344 — Posted: 2020-05-06
Time-adjusted Analysis Shows Weak Associations Between BCG Vaccination Policy and COVID-19 Disease Progression
Bodova, K., Boza, V., Brejova, B., Kollar, R., Mikusova, K., Vinar, T.
10.1101/2020.05.01.20087809 — Posted: 2020-05-06
Predictive mathematical models for the number of individuals infected with COVID-19
Fokas, A. S., Dikaios, N., Kastis, G. A.
10.1101/2020.05.02.20088591 — Posted: 2020-05-06
Associations of stay-at-home order and face-masking recommendation with trends in daily new cases and deaths of laboratory-confirmed COVID-19 in the United States
Xu, J., Hussain, S., Lu, G., Wei, S., Bao, W., Zhang, L.
10.1101/2020.05.01.20088237 — Posted: 2020-05-06 Discussion: Onsite
Geospatially Referenced Demographic Agent-Based Modeling of SARS-CoV-2-Infection (COVID-19) Dynamics and Mitigation Effects in a Real-world Community
Adler, S. O., Bodeit, O., Bonn, L., Goldenbogen, B., Haffner, J. E. L., Karnetzki, M., Korman, A., Krantz, M., Linding, R., Maintz, I., Mallis, L., Martinez de la Escalera, X., Moran Torres, R. U., Prawitz, H., Seeger, M., Segelitz, P., Wodke, J. A., Klipp, E.
10.1101/2020.05.03.20089235 — Posted: 2020-05-06
Benchmarking the CoVID-19 pandemic across countries and states in the U.S.A. under heterogeneous testing
Asahi, K., Undurraga, E. A., Wagner, R.
10.1101/2020.05.01.20087882 — Posted: 2020-05-06
Incorporating and Addressing Testing Bias Within Estimates of Epidemic Dynamics for SARS-CoV-2
Suhail, Y., Afzal, J., Kshitiz
10.1101/2020.05.02.20088120 — Posted: 2020-05-06
Comparison of two commercial molecular tests and a laboratory-developed modification of the CDC 2019-nCOV RT-PCR assay for the qualitative detection of SARS-CoV-2 from upper respiratory tract specimens
Moore, N. M., Li, H., Schejbal, D., Lindsley, J., Hayden, M.
10.1101/2020.05.02.20088740 — Posted: 2020-05-06
Potential biases arising from epidemic dynamics in observational seroprotection studies
Kahn, R., Kennedy-Shaffer, L., Grad, Y., Robins, J. M., Lipsitch, M.
10.1101/2020.05.02.20088765 — Posted: 2020-05-06

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).